Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bruker Corporation - Common Stock (NQ:BRKR)

38.71 -0.23 (-0.59%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Bruker Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Bruker Announces Quarterly Dividend
From Bruker Corporation
Via Business Wire
Bruker Announces Acquisition of Inscopix for Neuroscience Research
From Bruker Corporation
Via Business Wire
Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference
From Bruker Corporation
Via Business Wire
Bruker Reports Third Quarter 2022 Financial Results
From Bruker Corporation
Via Business Wire
Bruker Announces Date and Time of Third Quarter 2022 Earnings Release and Webcast
From Bruker Corporation
Via Business Wire
Bruker Launches New nanoElute® 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape® 2023 Software
From Bruker Corporation
Via Business Wire
Bruker Introduces Enabling New Scientific Capabilities for Cell Biology and Pathobiology Research with High-Field NMR Innovations
From Bruker Corporation
Via Business Wire
Bruker Announces Quarterly Dividend
From Bruker Corporation
Via Business Wire
Bruker Reports Second Quarter 2022 Financial Results
From Bruker Corporation
Via Business Wire
Bruker Announces Date and Time of Second Quarter 2022 Earnings Release and Webcast
From Bruker Corporation
Via Business Wire
Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research
From Bruker Corporation
Via Business Wire
Bruker Launches NMR-based Molecular Phenomics Clinical Research Tool for ‘Long COVID’ Multi-Organ Risk Assessment
From Bruker Corporation
Via Business Wire
Bruker is Ushering in the Age of Spatial Single-Cell Metabolomics
From Bruker Corporation
Via Business Wire
Bruker Presents High-Value Life Science, Materials Research and Applied Market Solutions at Analytica 2022
From Bruker Corporation
Via Business Wire
Bruker Introduces Enhanced 3D Holographic Stimulation for Optogenetics on its Ultima 2Pplus Multiphoton Microscope
From Bruker Corporation
Via Business Wire
Bruker Launches timsTOF HT with Greater Dynamic Range for Further Enhancing Unbiased, High-Confidence 4D Proteomics™
From Bruker Corporation
Via Business Wire
Bruker Introduces Novel Point-of-Need Applied Mass Spectrometry Tools for Accelerated Measurements without Chromatography
From Bruker Corporation
Via Business Wire
Bruker Announces Key Innovations for Highly Multiplexed Spatial Proteomics and Multiomic Tissue Imaging at Large Field-of-View
From Bruker Corporation
Via Business Wire
Bruker Corporation to Present at Jefferies 2022 Global Healthcare Conference
From Bruker Corporation
Via Business Wire
Bruker Announces Quarterly Dividend
From Bruker Corporation
Via Business Wire
Bruker and TOFWERK Form Strategic Partnership in High-Speed, Ultra-Sensitive Solutions for Applied and Industrial Markets
From Bruker Corporation
Via Business Wire
Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets
From Bruker Corporation
Via Business Wire
Bruker Reports First Quarter Financial Results
From Bruker Corporation
Via Business Wire
Bruker Demonstrates Novel and Unique Compact 1.0 GHz NMR Magnet
From Bruker Corporation
Via Business Wire
Bruker Launches Unique LiquidArray® Multiplex PCR Assays
From Bruker Corporation
Via Business Wire
Bruker Announces Date and Time of First Quarter 2022 Earnings Release and Webcast
From Bruker Corporation
Via Business Wire
Bruker Announces Key Innovations for Multiplexed Spatial Proteomics and Unbiased Multiomic Imaging for Cancer Research
From Bruker Corporation
Via Business Wire
IonSense, a Leader In DART™ Mass Spectroscopy, Announces Acquisition by Bruker to Accelerate DART-MS Methods and Applications Development
From IonSense Inc.
Via Business Wire
Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies
From Bruker Corporation
Via Business Wire
Bruker Expands dia-PASEF® on the timsTOF 4D Proteomics and Epiproteomics Platform to Identify up to 13,000 Protein Groups with 1% FDR
From Bruker Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.